Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Cytori Therapeutics Inc    CYTX

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2016 9,33 M
EBIT 2016 -20,3 M
Net income 2016 -21,9 M
Debt 2016 -
Yield 2016 -
Sales 2017 11,8 M
EBIT 2017 -20,8 M
Net income 2017 -21,8 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales2016 3,56x
Capi. / Sales2017 2,81x
Capitalization 33,2 M
More Financials
Company
Cytori Therapeutics, Inc. is a late stage cell therapy company.Its develops autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions.Data from preclinical studies and clinical trials suggest that Cytori Cell Therapy acts principally... 
More about the company
Surperformance© ratings of Cytori Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on CYTORI THERAPEUTICS INC
10:53p CYTORI THERAPEUTICS, INC. (NASDAQ : CYTX) Files An 8-K Results of Operations and..
10:09p CYTORI THERAPEUTICS : reports 4Q loss
10:04p CYTORI THERAPEUTICS, INC. : Results of Operations and Financial Condition, Finan..
09:26p Cytori Reports Fourth Quarter and Full Year 2016 Business and Financial Resul..
03/17 Cytori to Webcast Fourth Quarter Financial Results on March 23rd
03/03 CYTORI THERAPEUTICS, INC. (NASDAQ : CYTX) Files An 8-K Entry into a Material Def..
03/03 CYTORI THERAPEUTICS, INC. : Entry into a Material Definitive Agreement (form 8-K..
02/16 CYTORI THERAPEUTICS : An Application for the Trademark "CELBRUSH" Has Been Filed..
02/16 CYTORI THERAPEUTICS' : Trademark Application for "CELUTION" Filed
02/16 CYTORI THERAPEUTICS : Completes Acquisition of Azaya Therapeutics Assets, Initia..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
03/22DJMEDTRONIC : Files 8K - Other Events
03/17DJMEDTRONIC : Less-Invasive Treatment Yielded Similar Outcome as Open-Heart Surger..
03/11DJLUXOTTICA : Smart Glasses Get a Fresh Look -- WSJ
03/09DJLUXOTTICA : Eyewear Makers Take a Fresh Look at Smart Glasses
03/09DJLUXOTTICA : Eyewear Makers Rethink Smart Glasses
More sector news : Medical Equipment, Supplies & Distribution - NEC
News from SeekingAlpha
2016 Cytori Therapeutics' (CYTX) CEO Marc Hedrick on Q1 2016 Results - Earnings Ca..
2016 Cytori Therapeutics EPS in-line, beats on revenue
2016 Cytori Cell Therapy an Orphan Drug in Europe for scleroderma-related hand dys..
2016 Notable earnings after Tuesday?s close
2016 Cytori's late-stage study of ECCS-50 in scleroderma 50% enrolled; study to co..
Advertisement
Chart CYTORI THERAPEUTICS INC
Duration : Period :
Cytori Therapeutics Inc Technical Analysis Chart | CYTX | US23283K1051 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 7,25 $
Spread / Average Target 350%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Marc H. Hedrick President, Chief Executive Officer & Director
David M. Rickey Chairman
Tiago Girão CFO, Vice President & Head-Investor Relations
John K. Fraser Chief Scientist
Mark T. Marino Chief Medical Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CYTORI THERAPEUTICS IN..-4.14%33
MEDTRONIC PLC13.72%110 880
BAXTER INTERNATIONAL I..16.80%28 068
ZIMMER BIOMET HOLDINGS..17.62%24 410
HOYA CORPORATION9.69%18 912
C R BARD INC11.09%18 047
More Results